Meladura

Melatonin, the active ingredient in Meladura, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps regulate sleep patterns and is used to manage insomnia, sleep‑wake cycle disorders and jet lag in adults. The product complies with EU quality standards.

GNH USA supplies Meladura as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor pathway to regulate circadian rhythm and is used for several sleep‑related conditions.

Insomnia: improves sleep onset and maintenance in individuals with difficulty falling or staying asleep. Sleep‑wake cycle disorders: helps synchronize abnormal sleep patterns such as delayed sleep phase syndrome. Jet lag: reduces the time needed to adjust to new time zones after long‑distance travel.

Melatonin may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea - Vivid dreams or nightmares - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling - Mood changes including depression or anxiety - Hormonal effects like menstrual irregularities - Severe hypotension (very low blood pressure)

When considering melatonin therapy, several safety measures should be observed.

Pregnancy: consult a healthcare professional before use, as safety data are limited. Breastfeeding: discuss potential risks with a physician. Pediatric use: only under medical supervision, especially for chronic conditions. Drug interactions: review concomitant medications for possible interactions. Underlying conditions: assess for depression, seizure disorders, or autoimmune diseases before initiating therapy. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Melatonin can interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Immunosuppressants (e.g., cyclosporine): possible reduction in drug efficacy. - Central nervous system depressants (e.g., benzodiazepines): excessive sedation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: potential alteration of hormone levels. - Antidiabetic agents: possible effect on blood glucose control. - Antihypertensives: may enhance blood pressure‑lowering effect.